Pre-Close Trading Update

IXICO today provides the following pre-close trading update ahead of its preliminary results for the year ended 30 September 2015.

The Company is pleased to report revenues for the year at £3.1 million and other income at £1.0 million, in line with market expectations, giving combined total income of £4.1 million for the year. This compares to £4.3 million of total income (£3.4 million of revenue and £0.9 million of other income) for the 16 month period to 30 September 2014. Revenues in the year were achieved in the clinical trials business, including new contracts in Huntington’s Disease, together with initial revenues from the Company’s proprietary digital healthcare platform.

By |2017-10-10T16:31:53+00:0019 October 2015|Financial|